Your one-stop Solution for MEDICAL LEARNING & UPDATES

hidoc_medibot hidoc_medibot

Today's Updates

NeurologyLive® Brain Games: October 11, 2026 Louie Pasculli

Published Date: 15 Oct 2026

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is recent therapeutic advances in MS!

This Week on NeurologyLive® — October 12, 2026 Isabella Ciccone, MPH

Published Date: 15 Oct 2026

Here's some of what is coming soon to NeurologyLive® this week.

Individualizing Advanced Therapies in Parkinson Disease: Hubert Fernandez, MD Hubert Fernandez, MD, Louie Pasculli

Published Date: 15 Oct 2026

The director of the Center for Neurological Restoration at Cleveland Clinic discusses when to transition beyond oral medication and considerations for selecting device-aided therapies in PD.

What Comprehensive Disease Control Means for IBD, With David Rubin, MD David Rubin, MD

Published Date: 15 Oct 2026

A gastroenterologist explains why treating bowel inflammation alone isn't enough to call inflammatory bowel disease "controlled."

Individualizing IBD Care Beyond the Bowel, With David T. Rubin, MD David Rubin, MD

Published Date: 15 Oct 2026

David T. Rubin, MD, on the questions, screening tools, and system barriers standing between IBD care and the whole patient.

How Candida Moves From Mouth to Gut in IBD, With Iliyan D. Iliev, PhD Iliyan D. Iliev, PhD

Published Date: 15 Oct 2026

Weill Cornell investigator Iliyan D. Iliev, PhD, explains why fluconazole, not nystatin, cleared gut Candida in IBD.

LIBERTY: Prior Anti-Drug Antibodies Did Not Blunt SC Infliximab After Drug Holiday

Published Date: 15 Oct 2026

LIBERTY: Prior Anti-Drug Antibodies Did Not Blunt SC Infliximab After Drug Holiday

Mirikizumab Shows Early Efficacy in Pediatric UC in SHINE-2 Trial

Published Date: 15 Oct 2026

Mirikizumab Shows Early Efficacy in Pediatric UC in SHINE-2 Trial

Advances in Treating High-Impact Psoriasis from EADV 2026 Christopher G. Bunick, MD, PhD

Published Date: 15 Oct 2026

Chris Bunick, MD, PhD, discusses 52-week UnlIMMited data showing risankizumab sustained clearance, itch relief, and quality-of-life gains.

EADV Congress 2026: 5 Atopic Dermatitis Headlines to Know

Published Date: 15 Oct 2026

EADV Congress 2026: 5 Atopic Dermatitis Headlines to Know

Knowledge Hub

Oncology

Oncolytic Virus Therapy for Treatment-Resistant Tumors: Mechanisms, Clinical Evidence, and Future Directions 

Comprehensive review of oncolytic virus therapy for treatment-resistant tumors, focusing on mechanisms, clinical evidence, and future directions.

Oncology

Targeted RNA Delivery to Tumors: Mechanisms, Clinical Implications, and Future Directions 

Comprehensive review on targeted RNA delivery to tumors, covering mechanisms, clinical implications, and latest advances for oncology professionals.

Oncology

Cancer Care and Geographic Inequality: Bridging the Gap in Oncology Outcomes 

A scientific review of how geographic inequality impacts cancer care and outcomes, with evidence-based insights for healthcare professionals.

Oncology

Extracorporeal Circuit Effects on Monoclonal Antibody Recovery 

Review of how extracorporeal circuits impact monoclonal antibody therapy in clinical practice.

Oncology

Pediatric Cancer Organoid Biobanks and Quality Standards

Oncology

Fertility Preservation Considerations Before Hematologic Cancer Therapy

Oncology

Digital Specimen Tracking for Precision Oncology Workflows

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

Dr. Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Dr Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Dr. Todd Bauer and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Dr. Poonam Patil and 1 more

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot